Author Interviews, Education / 03.11.2025
RBT vs. BCBA: What’s the Difference?
[caption id="attachment_71246" align="aligncenter" width="500"]
Photo by Husna Miskandar on Unsplash[/caption]
In the field of applied behavior analysis (ABA), you will often see the qualifications “RBT” and “BCBA.” While both play important roles in behaviour-analytic services, they differ significantly in terms of education, responsibilities, autonomy, and career trajectory.
For those preparing to enter the field or advance their credentials, using an RBT mock exam can be an excellent way to test your knowledge, identify areas for improvement, and build confidence before certification. Understanding these differences is essential if you’re considering entering the field, either as a direct service provider or a supervisor/analyst.
Photo by Husna Miskandar on Unsplash[/caption]
In the field of applied behavior analysis (ABA), you will often see the qualifications “RBT” and “BCBA.” While both play important roles in behaviour-analytic services, they differ significantly in terms of education, responsibilities, autonomy, and career trajectory.
For those preparing to enter the field or advance their credentials, using an RBT mock exam can be an excellent way to test your knowledge, identify areas for improvement, and build confidence before certification. Understanding these differences is essential if you’re considering entering the field, either as a direct service provider or a supervisor/analyst.
Dr. Serena Guo[/caption]
Serena Jingchuan Guo, MD PhD
Assistant Professor
Department of Pharmaceutical Outcomes and Policy
University of Florida College of Pharmacy
[caption id="attachment_71231" align="alignleft" width="125"]
Dr. Hao Dai[/caption]
Hao Dai, PhD
Postdoctoral Fellow
Department of Biostatistics & Health Data Science
Indiana University School of Medicine
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Obesity and type 2 diabetes are both known to increase the risk of several cancers. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have become very popular for both glycemic control and weight loss, but their long-term effects on cancer risk are still unclear. Using a large real-world dataset, we emulated a target trial comparing more than 43,000 GLP-1RA users to matched non-users.
We found that GLP-1RA use was associated with a significantly lower overall cancer risk.
Dr. Dehghani[/caption]
MedicalResearch.com Interview with:
Ali Dehghani, DO
Department of Medicine
University Hospitals Cleveland Medical Center / Case Western Reserve University
Presenting Author, IDWeek 2025
MedicalResearch.com: What is the background for this study?
Response: Shingles (herpes zoster) is caused by reactivation of the varicella-zoster virus, which can inflame blood vessels and the nervous system. Evidence over the past decade has linked shingles to higher risks of heart attack, stroke, and dementia—but it was unclear whether the shingles vaccine might lessen those long-term effects.
[caption id="attachment_71061" align="aligncenter" width="500"]
Clubfoot
Dr. Jiyoung Ahn[/caption]
MedicalResearch.com Interview with:
Jiyoung Ahn, PhD
Dr. King[/caption]
Brett King, MD, PHD
Dr. King was named an American Academy of Dermatology (AAD) “Patient Care Hero”
for his work treating patients with severe alopecia areata
Dermatology Physicians of Connecticut
Fairfield, Connecticut
MedicalResearch.com: What is the background for this study? Would you briefly explain the condition of Alopecia Areata?
Response: Alopecia Areata (AA), an autoimmune form of hair loss, is common and its treatment has been revolutionized in the past ~3 years with approvals of 3 JAK inhibitors, bariticinib, ritlecitinib and deuruxolitinib. Prior to these approvals, off label treatments included the JAK inhibitors tofacitinib and ruxolitinib.